Study factors that predict survival after aggressive meningioma surgery
Part of Brain & nervous system, Cancer clinical trials.
This study looks at people who had surgery for more aggressive meningiomas (grade 2 or 3) and tries to learn what factors relate to survival. The results may help doctors better predict outcomes for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery for an atypical meningioma (grade 2) or an anaplastic meningioma (grade 3)
- Your surgery happened between 1999 and 2019
- You had follow-up after surgery (you were not lost to follow-up)
- The study uses your past medical and surgery information
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether radiation given after complete surgery can reduce regrowth of atypical (grade II) meningioma in certain people. It is mainly for tumors that did not involve the brain’s venous sinus and for patients who can safely have follow-up brain MRI scans.
This study measures how thinking and memory change after surgery to remove a meningioma near the front or side of the brain. It may help doctors better understand what to expect and how cognitive recovery can differ from person to person.
This study looks at how your tumor's genes, personal health habits, and other factors affect your long-term health after a meningioma diagnosis. You'll be asked to complete surveys about your health and experiences—no new treatments or procedures are involved.
This trial tests a type of radiation (protons) for brain tumors called atypical or anaplastic meningiomas that need radiotherapy. It may help by aiming radiation more precisely while also learning the safest and most effective dose.
This study is looking at tiny particles called extracellular vesicles in the blood of people with meningioma, a type of brain tumor. The goal is to learn more about these particles and how they relate to the tumor, which may help in understanding the disease better.
This study tests a type of focused radiation therapy (called stereotactic radiosurgery) given after surgery for certain meningiomas. The goal is to see if this treatment helps prevent the tumor from coming back, and to check its safety.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.